873 results on '"SPADARO, Giuseppe"'
Search Results
2. High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study
3. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
4. Is there a role for microbiome-based approach in common variable immunodeficiency?
5. Gender dimorphism in IgA subclasses in T2-high asthma
6. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
7. Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function
8. Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
9. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
10. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
11. Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency?
12. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
13. Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma
14. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
15. Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
16. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.
17. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
18. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
19. Lanadelumab Effectiveness and Safety in Adolescent Patients With Hereditary Angioedema Aged 12 to <18 Years: Pooled Results From the Real-World ENABLE and EMPOWER Studies
20. Severe asthma: One disease and multiple definitions
21. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
22. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
23. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
24. Roles of Immune Cells in Hereditary Angioedema
25. High Prevalence of Long COVID in Common Variable Immunodeficiency:An Italian Multicentric Study
26. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
27. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality
28. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
29. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
30. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder
31. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
32. Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency
33. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)
34. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies
35. The Severe Asthma Network in Italy: Findings and Perspectives
36. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
37. First Report of De Novo Nivolumab-Induced Oligoarthritis in a Young Man With Relapsing Classic Hodgkin Lymphoma
38. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.
39. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
40. Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
41. Early ENT Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
42. Real-world effectiveness and characteristics of Super-Responders to Mepolizumab and Benralizumab in severe eosinophilic asthma and EGPA
43. Could it be hereditary angioedema?—Perspectives from different medical specialties
44. Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
45. Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
46. First Report of De Novo Nivolumab-Induced Oligoarthritis in a Young Man With Relapsing Classic Hodgkin Lymphoma
47. Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study
48. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
49. Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients
50. A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.